- Home
- FVRR vs IOVA Comparison
FVRR vs IOVA Comparison
Compare FVRR & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FVRR
- IOVA
- Stock Information
- Founded
- FVRR 2010
- IOVA 2007
- Country
- FVRR Israel
- IOVA United States
- Employees
- FVRR N/A
- IOVA N/A
- Industry
- FVRR Business Services
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FVRR Consumer Discretionary
- IOVA Health Care
- Exchange
- FVRR Nasdaq
- IOVA Nasdaq
- Market Cap
- FVRR 957.0M
- IOVA 1.0B
- IPO Year
- FVRR 2019
- IOVA N/A
- Fundamental
- Price
- FVRR $30.75
- IOVA $1.75
- Analyst Decision
- FVRR Buy
- IOVA Strong Buy
- Analyst Count
- FVRR 12
- IOVA 9
- Target Price
- FVRR $34.91
- IOVA $15.50
- AVG Volume (30 Days)
- FVRR 544.3K
- IOVA 13.9M
- Earning Date
- FVRR 05-07-2025
- IOVA 05-08-2025
- Dividend Yield
- FVRR N/A
- IOVA N/A
- EPS Growth
- FVRR 127.71
- IOVA N/A
- EPS
- FVRR 0.49
- IOVA N/A
- Revenue
- FVRR $405,141,000.00
- IOVA $212,679,000.00
- Revenue This Year
- FVRR $12.11
- IOVA $182.20
- Revenue Next Year
- FVRR $8.62
- IOVA $62.10
- P/E Ratio
- FVRR $60.72
- IOVA N/A
- Revenue Growth
- FVRR 10.41
- IOVA 11070.12
- 52 Week Low
- FVRR $20.78
- IOVA $2.70
- 52 Week High
- FVRR $36.11
- IOVA $13.60
- Technical
- Relative Strength Index (RSI)
- FVRR 71.53
- IOVA 23.78
- Support Level
- FVRR $26.04
- IOVA $3.02
- Resistance Level
- FVRR $27.20
- IOVA $3.31
- Average True Range (ATR)
- FVRR 1.01
- IOVA 0.24
- MACD
- FVRR 0.53
- IOVA -0.09
- Stochastic Oscillator
- FVRR 98.77
- IOVA 4.81
About FVRR Fiverr International Ltd. no par value
Fiverr International Ltd is involved in buying and selling digital services in the same fashion as physical goods on an e-commerce platform. It is set out to design a digital marketplace that is built with a comprehensive SKU-like services catalog and a search, finds, and order process that mirrors a typical e-commerce transaction. The service offerings of the company include Graphics and Design, Digital Marketing, Wiring and Translation, and Video and Animation among others.
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.